Darapladib Market In Global
Darapladib is a reversible lipoprotein-associated phospholipase A2 inhibitor.
This ... Read More
Ebselen is an organoselenium compound that displays anti-inflammatory and antioxidant properties.
This report contains market size and forecasts of Ebselen in global, including the following market information:
Global Ebselen Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Ebselen Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Ebselen companies in 2021 (%)
The global Ebselen market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ebselen include Bio-Techne, Cayman Chemical, Abcam, Merck, Enzo Biochem, Santa Cruz Biotechnology, Focus Biomolecules, TargetMol and Abcam, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ebselen manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ebselen Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Ebselen Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Ebselen Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Ebselen Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Ebselen Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Ebselen Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ebselen revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Ebselen revenues share in global market, 2021 (%)
Key companies Ebselen sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Ebselen sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bio-Techne
Cayman Chemical
Abcam
Merck
Enzo Biochem
Santa Cruz Biotechnology
Focus Biomolecules
TargetMol
Abcam
Selleck Chemicals
MP Biomedicals
Biosynth Carbosynth
Biorbyt
StressMarq Biosciences
AbMole
BioVision
APExBIO Technology
LKT Laboratories
Beyotime
TCI
Darapladib is a reversible lipoprotein-associated phospholipase A2 inhibitor.
This ... Read More
Anacetrapib is a CETP inhibitor being developed to treat hypercholesterolemia and prevent cardiov ... Read More
Dalcetrapib is a CETP inhibitor.Inhibition of CETP is a target to increase HDL-cholesterol and po ... Read More
Evacetrapib is a cholesterol ester transfer protein inhibitor that exhibits anti-atherosclerotic ... Read More